Thomas Klimkait
- Infectious Diseases top 0.2%
- Virology top 0.1%
- Molecular Biology top 5%
- Epidemiology top 2%
- Oncology top 2%
- Co-authors
- Klaus StrebelMaría Ángeles MartínHans H. HirschMichael J. MihatschWendy A. KnowlesJürg SteigerJakob PasswegMichael Dickenmann
- Topics
- HIV Research and Treatment (129 papers)HIV/AIDS drug development and treatment (115 papers)HIV/AIDS Research and Interventions (103 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Thomas Klimkait
183 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Infectious Diseases 3.7k
- Virology 3.6k
- Molecular Biology 1.7k
- Epidemiology 1.4k
- Oncology 1.4k
Countries citing papers authored by Thomas Klimkait
This map shows the geographic impact of Thomas Klimkait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Klimkait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Klimkait more than expected).
Fields of papers citing papers by Thomas Klimkait
This network shows the impact of papers produced by Thomas Klimkait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Klimkait. The network helps show where Thomas Klimkait may publish in the future.
Co-authorship network of co-authors of Thomas Klimkait
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Klimkait. A scholar is included among the top collaborators of Thomas Klimkait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Klimkait. Thomas Klimkait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 3 | |
| 7 | 13 | |
| 8 | 10 | |
| 9 | 2 | |
| 10 | 19 | |
| 11 | 42 | |
| 12 | 16 | |
| 13 | 4 | |
| 14 | 39 | |
| 15 | 6 | |
| 16 | 12 | |
| 17 | 0 | |
| 18 | Impact of newly HIV diagnosed individuals on the transmission of drug resistance | 0 |
| 19 | 'Restriction-PCR' - a Superior Replacement for Restriction Endonucleases in DNA Cloning Applications | 3 |
| 20 | 9 |
About Thomas Klimkait
Thomas Klimkait is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 186 papers that have together received 7.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (129 papers), HIV/AIDS drug development and treatment (115 papers) and HIV/AIDS Research and Interventions (103 papers). The work is most often cited by research in Virology (3.6k citations), Infectious Diseases (3.7k citations) and Transplantation (309 citations). Thomas Klimkait has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Klaus Strebel, María Ángeles Martín, Hans H. Hirsch, Michael J. Mihatsch, Wendy A. Knowles, Jürg Steiger, Jakob Passweg, Michael Dickenmann, François Hamy and Huldrych F. Günthard. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.